These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics. Hovmand OR; Poulsen ED; Arnfred S J Psychopharmacol; 2024 Jan; 38(1):19-32. PubMed ID: 37969069 [TBL] [Abstract][Full Text] [Related]
11. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Lyvers M; Meester M J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892 [TBL] [Abstract][Full Text] [Related]
13. The psychedelic effects of cannabis: A review of the literature. Wolinsky D; Barrett FS; Vandrey R J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321 [TBL] [Abstract][Full Text] [Related]
15. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains. Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708 [TBL] [Abstract][Full Text] [Related]
16. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. Palhano-Fontes F; Andrade KC; Tofoli LF; Santos AC; Crippa JA; Hallak JE; Ribeiro S; de Araujo DB PLoS One; 2015; 10(2):e0118143. PubMed ID: 25693169 [TBL] [Abstract][Full Text] [Related]
17. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Smigielski L; Scheidegger M; Kometer M; Vollenweider FX Neuroimage; 2019 Aug; 196():207-215. PubMed ID: 30965131 [TBL] [Abstract][Full Text] [Related]
19. Psychedelics in the treatment of unipolar and bipolar depression. Bosch OG; Halm S; Seifritz E Int J Bipolar Disord; 2022 Jul; 10(1):18. PubMed ID: 35788817 [TBL] [Abstract][Full Text] [Related]